IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Mass General Brigham, Inc

Q2 2024 Holdings

Filed 2024-07-31 | 4 holdings | $20.5M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Revolution Medicines Inc(RVMD)COM76155X100$13.1M338,19163.9%
Pliant Therapeutics Inc(PLRX)COM729139105$3.1M288,69015.1%
Tango Therapeutics Inc(TNGX)COM87583X109$3.0M354,19214.8%
Fulcrum Therapeutics Inc(FULC)COM359616109$1.3M205,3566.2%